A randomized controlled trial to study the effect of yoga therapy on cardiac function and n terminal pro BNP in heart failure

Integrative Medicine Insights

Volumn , Issue 9, 2014, Pages

  Krishna, Bandi Hari ^a   Pal, Pravati ^a   Pal, G K ^a   Balachander, J ^a   Jayasettiaseelon, E ^a   Sreekanth, Y ^a   Sridhar, M G ^a   Gaur, G S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ejection fraction; Heart failure; NT pro BNP; Tei index; Yoga therapy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART FAILURE; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFORMANCE INDEX; PARALLEL DESIGN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; YOGA;

EID: 84899112103     PISSN: None     EISSN: 11773936     Source Type: Journal    
DOI: 10.4137/IMI.S13939     Document Type: Article

References (23)

1. Adams KF Jr, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J. 1998;135:S204-S215.
2. Masoudi FA, Baillie CA, Wang Y, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165:2069-76.
3. Wilson JR, Ferraro N. Exercise intolerance in patients with chronic left heart failure: relation to oxygen transport and ventilatory abnormalities. Am J Cardiol. 1983;51:1358-63.
4. Bruch C, Schmermund A, Marin D, et al. Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J. 2000;21:1888-95.
5. Belagavi AC, Rao M, Pillai AY, Srihari US. Correlation between NT proBNP and left ventricular ejection fraction in elderly patients presenting to emergency department with dyspnoea. Indian Heart J. 2012;64:302-4.
6. Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag. 2010;6:411-8.
7. Lee SC, Stevens TL, Sandberg SM, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail. 2002;8:149-54.
8. Walke LM, Byers AL, Gallo WT, Endrass J, Fried TR. The association of symptoms with health outcomes in chronically ill adults. J Pain Symptom Manage. 2007;33:58-66.
9. Bulavin VV, Kliuzhev VM, Kliachkin LM, Lakshmankumar, Zuikhin ND, Vlasova TN, et al. [Elements of yoga therapy in the combined rehabilitation of myocardial infarct patients in the functional recovery period]. Vopr Kurortol Fizioter Lech Fiz Kult. 1993:7-9.
10. Pullen PR, Nagamia SH, Mehta PK, et al. Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure. J Card Fail. 2008;14:407-13.
11. Mahajan AS, Reddy KS, Sachdeva U. Lipid profile of coronary risk subjects following yogic lifestyle intervention. Indian Heart J. 1999;51:37-40.
12. Selvamurthy W, Sridharan K, Ray US, et al. A new physiological approach to control essential hypertension. Indian J Physiol Pharmacol. 1998;42:205-13.
13. Ornish D. Can lifestyle changes reverse coronary heart disease? World Rev Nutr Diet. 1993;72:38-48.
14. Tran MD, Holly RG, Lashbrook J, Amsterdam EA. Effects of hatha yoga practice on the health-related aspects of physical fitness. Prev Cardiol. 2001;4:165-70.
15. Biman Bihari Paul. Effect of shavasan practices on coronary heart patients with special reference to shavasan and meditation. Int Sci Yoga J Sense. 2011;1:86-91.
16. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2:358-67.
17. Quinones MA, Waggoner AD, Reduto LA, et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 1981;64:744-53.
18. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26:357-66.
19. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR, Seward JB, et al. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc. 1994;69:212-24.
20. Cohn JN. The management of chronic heart failure. N Engl J Med. 1996;335:490-8.
21. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995;26:135-6.
22. Pullen PR, Thompson WR, Benardot D, et al. Benefits of yoga for African American heart failure patients. Med Sci Sports Exerc. 2010;42:651-7.
23. Tran MD, Holly RG, Lashbrook J, Amsterdam EA. Effects of hatha yoga practice on the health-related aspects of physical fitness. Prev Cardiol. 2001;4:165-70.